Procter & Gamble Health Limited (PGHL) announced its unaudited financial results for the quarter ended December 31, 2025, following a Board of Directors meeting held on February 6, 2026. The meeting commenced at 12:11 p.m. and concluded at 2:23 p.m. During the meeting, the Board declared an interim dividend for the Financial Year 2025-26 amounting to ₹160 per equity share. This includes a one-time special dividend of ₹50 per equity share. The dividend is scheduled to be paid on or before March 4, 2026. For the quarter ended December 31, 2025, the company reported Revenue from Operations of ₹37,386 lakhs. Total Income stood at ₹37,822 lakhs, with Total Expenses at ₹26,940 lakhs. Profit Before Tax was ₹10,882 lakhs, and Net Profit for the period was ₹7,759 lakhs. Earnings per share (EPS) before exceptional items were ₹46.74. The record date for the interim dividend eligibility has been set as February 12, 2026. The financial results have been reviewed by the Audit Committee and the Statutory Auditors, with an unmodified conclusion.
